Becton Dickinson and Company

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Becton Dickinson and Company
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
BDX
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000010795

Board of directors

Follow this board

Chief executives

Thomas E. Polen Jr. · Chairman, CEO and President
Dates unknown

Board connections

11 of this board's directors also sit on 20 other boards.

Network of Becton Dickinson and Company's board connections Celanese Corporation Celanese Corporation Dollar Tree Inc. Dollar Tree Inc. Eikon Therapeutics Inc. Eikon Therapeutics Inc... Equitable Holdings Inc. Equitable Holdings Inc... Exelixis Inc. Exelixis Inc. Fortrea Holdings Inc. Fortrea Holdings Inc. Halozyme Therapeutics Inc. Halozyme Therapeutics... Insulet Corporation Insulet Corporation Kyntra Bio Inc. Kyntra Bio Inc. Lowe's Companies Inc. Lowe's Companies Inc. Maravai LifeSciences Holdings Inc. Maravai LifeSciences H... Orthofix Medical Inc. Orthofix Medical Inc. Phillips 66 Phillips 66 QUALCOMM Incorporated QUALCOMM Incorporated Quest Diagnostics Incorporated Quest Diagnostics Inco... RTX Corporation RTX Corporation Bertram L. Scott Bertram L. Scott Catherine M. Burzik Catherine M. Burzik Gregory Hayes Gregory Hayes Jacqueline Wright Jacqueline Wright Jeffrey William Henderson Jeffrey William Hend... R. Andrew Eckert R. Andrew Eckert Robert Luther Huffines Robert Luther Huffin... Timothy M. Ring Timothy M. Ring William M. Brown William M. Brown Becton Dickinson and Compa...
Shared director Other board Same sector +4 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$2,766,887
21 sales by 5 insiders
Date Insider Transaction Shares Price Value
Sep 2, 2026 Roque Vitor Officer (EVP & Chief Financial Officer) Shares withheld for tax −190 — —
Aug 26, 2026 Feld Michael Officer (EVP, Chief Revenue Officer) Open-market sale −165 $188.49 $31,101
Aug 20, 2026 Feld Michael Officer (EVP, Chief Revenue Officer) Shares withheld for tax −1,049 — —
Aug 13, 2026 Thomas E. Polen Jr. Director, Officer (Chairman, CEO and President) Option exercise +43,278 $167.25 $7,238,246
Aug 13, 2026 Thomas E. Polen Jr. Director, Officer (Chairman, CEO and President) Sold back to the company −39,126 $185.00 $7,238,310
Aug 13, 2026 Thomas E. Polen Jr. Director, Officer (Chairman, CEO and President) Open-market sale −4,152 $185.00 $768,120
Aug 11, 2026 Goette Roland Officer (EVP and President, EMEA) Open-market sale −2,438 $180.84 $440,888
Jul 27, 2026 Feld Michael Officer (EVP, Chief Revenue Officer) Open-market sale −75 $157.13 $11,785
Jul 2, 2026 Muhsin Bilal Officer (EVP & President Connected Care) Shares withheld for tax −1,935 — —
Jul 1, 2026 Muhsin Bilal Officer (EVP & President Connected Care) Grant or award +14,342 — —
Jun 26, 2026 Feld Michael Officer (EVP, Chief Revenue Officer) Open-market sale −75 $152.80 $11,460
Jun 24, 2026 Garrison Michael David Officer (EVP & Pres Med.Essntl&BioPharm) Open-market sale −1,100 $145.66 $160,226
Jun 10, 2026 Garrison Michael David Officer (EVP & Pres Med.Essntl&BioPharm) Open-market sale −1,100 $151.48 $166,628
Jun 1, 2026 Thomas E. Polen Jr. Director, Officer (Chairman, CEO and President) Option exercise +20,209 $126.16 $2,549,567
Jun 1, 2026 Menziuso Peter Officer (EVP and President, BDI) Grant or award +14,258 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.